Clinical Characteristics of Mild Patients with Breakthrough Infection of Omicron Variant in China after Relaxing the Dynamic Zero COVID-19 Policy

Clinical Characteristics of Mild Patients with Breakthrough Infection of Omicron Variant in China after Relaxing the Dynamic Zero COVID-19 Policy

For SARS-CoV-2 mutants, the effectiveness of the COVID-19 vaccines is still controversial. In this study, we aimed to investigate the clinical characteristics of Omicron-infected patients who completed primary immunization and booster immunization, respectively, during the rapid propagation of the O...

Full description

Bibliographic Details
Main Authors:	Yingyu He, Fang Zhang, Yan Liu, Zhou Xiong, Shangen Zheng, Wanbing Liu, Lei Liu
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Vaccines
Subjects:	COVID-19 omicron breakthrough infection booster vaccination primary vaccination
Online Access:	https://www.mdpi.com/2076-393X/11/5/968

Similar Items

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations
by: Thomas Perkmann, et al.
Published: (2023-08-01)

Effect of second booster vaccination on clinical outcomes of Omicron-variant breakthrough infection: A propensity score matching cohort study
by: Denggao Peng, et al.
Published: (2024-01-01)

Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants
by: Liqiu Jia, et al.
Published: (2022-07-01)

Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational studyResearch in context
by: Ralf Duerr, et al.
Published: (2023-11-01)

COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
by: Dorota Zarębska-Michaluk, et al.
Published: (2022-07-01)

Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study
by: Makoto Saito, et al.
Published: (2024-02-01)

Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis
by: Masataro Toda, et al.
Published: (2023-07-01)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
by: Elisa Regenhardt, et al.
Published: (2023-05-01)

A New Chapter in the COVID-19 Pandemic: the Characteristics of Omicron Variant and A New Step for Scientific Epidemic Prevention and Control
by: LI Yi, et al.
Published: (2023-01-01)

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice
by: Jianyang Liu, et al.
Published: (2023-12-01)

Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations
by: Donald J. Alcendor, et al.
Published: (2023-04-01)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
by: Rajkumar Chinnadurai, et al.
Published: (2022-03-01)

Breakthrough infections and acceptance of COVID-19 vaccine boosters: A survey analysis
by: Christina W. Stevens, et al.
Published: (2023-12-01)

A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
by: Hassen Mohammed, et al.
Published: (2023-01-01)

Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination1
by: Hongyu Wang, et al.
Published: (2023-12-01)

Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial
by: Yayun Liu, et al.
Published: (2023-11-01)

Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
by: Vivek P. Chavda, et al.
Published: (2022-02-01)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
by: Zunera Jamal, et al.
Published: (2022-09-01)

Interactive effect of booster vaccination and vitamin D status on antibody production of Omicron variant‐infected adults: A real‐world cohort study
by: Denggao Peng, et al.
Published: (2023-10-01)

Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
by: Sharon Walmsley, et al.
Published: (2023-12-01)

The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
by: Yuntao Zou, et al.
Published: (2022-07-01)

Effectiveness of Mix-and-Match Vaccination in Preventing SARS-CoV-2 Omicron Variant Infection in Taiwan: A Test-Negative Control Study
by: Yu-Tung Huang, et al.
Published: (2023-08-01)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
by: Birte Möhlendick, et al.
Published: (2022-06-01)

Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
by: Milja Belik, et al.
Published: (2023-01-01)

Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study
by: Xiaofeng He, et al.
Published: (2023-10-01)

Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand
by: Karan Thakkar, et al.
Published: (2023-12-01)

Modeling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Malaysia
by: Karan Thakkar, et al.
Published: (2023-12-01)

Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey
by: Shijie Qin, et al.
Published: (2023-12-01)

Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant
by: Zhongcheng Zhou, et al.
Published: (2022-06-01)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
by: Tao Li, et al.
Published: (2023-12-01)

Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
by: Barbara Grüne, et al.
Published: (2022-06-01)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
by: Shohei Yamamoto, et al.
Published: (2023-05-01)

The importance of booster vaccination in the context of Omicron wave
by: Zichun Wei, et al.
Published: (2022-09-01)

Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA Project
by: Stefano Porru, et al.
Published: (2023-07-01)

Unveiling a New Perspective on Distinguishing Omicron Breakthrough Cases and Postimmune COVID-19-Naive Individuals: Insights from Antibody Profiles
by: Shihan Zhang, et al.
Published: (2023-08-01)

Real-world effectiveness of full and booster mRNA vaccination for coronavirus disease 2019 against disease severity during the delta- and omicron-dominant phases: A propensity score-matched cohort study using the nationwide registry data in Japan
by: Tetsuya Suzuki, et al.
Published: (2024-02-01)

Efficacy of the COVID-19 vaccination in patients with asymptomatic or mild illness during the Omicron epidemic in Guangzhou: a multi-centre retrospective cohort study
by: Yuanda Xu, et al.
Published: (2024-12-01)

Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression
by: Nando Reza Pratama, et al.
Published: (2022-12-01)

Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies
by: Shangchen Song, et al.
Published: (2023-06-01)

Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic?
by: Kaixi Ding, et al.
Published: (2022-04-01)